BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21277536)

  • 1. Office management of melanoma patients.
    Brown MD
    Semin Cutan Med Surg; 2010 Dec; 29(4):232-7. PubMed ID: 21277536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing trends in melanoma treatment and the expanding role of the dermatologist.
    Brown MD; Johnson TM; Swanson NA
    Dermatol Clin; 1991 Oct; 9(4):657-67. PubMed ID: 1934641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inpatient and outpatient follow-up of grade I malignant melanoma].
    Cordel N; Safa G; Balguerie X; De Preville P; Modeste A; Courville P; Boivin C; Pellerin A; Ziade J; Thiberville G; Laaengh-Michel N; Neveu C; Young P; Lauret P; Joly P
    Ann Dermatol Venereol; 2000; 127(6-7):579-83. PubMed ID: 10930854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should all melanoma patients undergo sentinel lymph node biopsy?
    Ra JH; McMasters KM; Spitz FR
    Curr Opin Oncol; 2006 Mar; 18(2):185-8. PubMed ID: 16462189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of malignant melanoma.
    Kroon BB; Nieweg OE
    Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of sentinel lymph node biopsy in the management of thin melanoma.
    Wong SL
    Am J Surg; 2005 Aug; 190(2):196-9. PubMed ID: 16023430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
    Cormier JN; Xing Y; Ding M; Lee JE; Mansfield PF; Gershenwald JE; Ross MI; Du XL
    J Clin Oncol; 2005 Sep; 23(25):6054-62. PubMed ID: 16135473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
    Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
    Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France.
    Grange F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A
    Arch Dermatol; 2008 May; 144(5):629-36. PubMed ID: 18490589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma pathology: important issues for clinicians involved in the multidisciplinary care of melanoma patients.
    Scolyer RA; Prieto VG
    Surg Oncol Clin N Am; 2011 Jan; 20(1):19-37. PubMed ID: 21111957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AJCC melanoma staging update: impact on dermatopathology practice and patient management.
    Piris A; Mihm MC; Duncan LM
    J Cutan Pathol; 2011 May; 38(5):394-400. PubMed ID: 21385199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous malignant melanoma: a primary care perspective.
    Shenenberger DW
    Am Fam Physician; 2012 Jan; 85(2):161-8. PubMed ID: 22335216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The skin overlying the sentinel lymph node: a full thickness skin graft donor site after local excision for cutaneous melanoma].
    Chennoufi M; Guihard T; Lantieri L
    Ann Chir Plast Esthet; 2007 Feb; 52(1):35-8. PubMed ID: 16857304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of surgery in the treatment of malignant melanoma].
    Péley G; Farkas E; Mátrai Z; Rényi-Vámos F; Kovács T; Köves I
    Magy Onkol; 2003; 47(1):69-77. PubMed ID: 12704458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma staging: facts and controversies.
    Forschner A; Eigentler TK; Pflugfelder A; Leiter U; Weide B; Held L; Meier F; Garbe C
    Clin Dermatol; 2010; 28(3):275-80. PubMed ID: 20541679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical treatment of melanoma: role of the sentinel lymph node].
    Marrazzo A; Cardinale G; Noto A; Casà L; Taormina P; Barbera G
    Chir Ital; 2003; 55(4):525-31. PubMed ID: 12938597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.